Alfredo Papa

Plain English
This study focused on how well people can adapt their coping strategies to different stress situations, aiming to measure this flexibility in a new way. Researchers looked at 343 participants and found that when people's coping strategies matched the stress they faced, they reported higher life satisfaction and lower psychological distress. Interestingly, having a wide range of coping strategies actually linked to feeling worse, highlighting that not all coping is effective. Who this helps: This research benefits psychologists and mental health professionals working with patients dealing with stress.

Plain English
This study looked at a new tool called the MTS™ Synergy Application System designed to test how well different antibiotics work together against drug-resistant bacteria. Researchers tested the system in 11 hospitals in Italy and found that it matched the standard testing method 98.4% of the time and was very consistent across different locations (96.7%). This matters because it provides a simpler and more reliable way for labs to evaluate antibiotic combinations, which is crucial for treating infections caused by bacteria that don’t respond to standard treatments. Who this helps: This helps doctors and patients dealing with drug-resistant infections.

Plain English
This study focused on reflex syncope, which is when children suddenly lose consciousness, often due to non-serious causes. Researchers found that most cases can be managed through some simple strategies like staying hydrated and increasing salt intake, but a structured approach to diagnosing serious causes like heart issues is essential, particularly using tools like ECG tests. This matters because it helps doctors ensure children get the right care without over-treating those whose fainting spells are not caused by serious medical issues. Who this helps: Patients and their families navigating healthcare for pediatric fainting episodes.

Plain English
This study looked at ways to improve the detection and analysis of enteroviruses, which can cause illnesses in children ranging from mild colds to serious conditions. Researchers found that Next-Generation Sequencing (NGS) offers a better way to fully analyze these viruses, helping to track outbreaks and better understand their spread. Implementing NGS in labs faces challenges, but the experts recommend practical steps to make it more widely available and standardized. Who this helps: This benefits patients, doctors, and public health officials working with enteroviral infections.

Plain English
This study looked at ways to prevent acute diverticulitis, a painful condition that affects the colon, in nearly 2,000 patients with newly diagnosed diverticular disease. Researchers followed the patients for three years and found that those on a high-fiber diet had a 5.9% risk of developing the condition, while patients taking mesalamine faced a 9.5% risk, and those on a combination of mesalamine and rifaximin had a 17.1% risk. Notably, mesalamine significantly reduced the risk of diverticulitis in patients with more severe inflammation, showing a 77% to 84% lower risk compared to other treatments. Who this helps: This research benefits patients suffering from diverticular disease by helping doctors choose better treatments to prevent diverticulitis.

Plain English
This study looked at the impact of biosimilars, a type of medication, on the treatment costs for inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis in Italy. Researchers found that while the number of people with these diseases increased significantly—from 146.6 to 203.6 cases of Crohn's disease per 100,000 people, and from 303.2 to 408.3 for ulcerative colitis—treatment costs for advanced therapies dropped by nearly 21%, from about €1.48 million to €1.17 million. This is important because it shows that more people are receiving effective treatment for IBD while overall costs are decreasing, largely due to the use of biosimilars that are more affordable than original biologics. Who this helps: This benefits patients with inflammatory bowel diseases by providing more affordable treatment options.

Plain English
This study examined whether adding 5-aminosalicylic acid (5-ASA) affects the effectiveness of Janus kinase inhibitors (JAKi) in treating ulcerative colitis (UC). Researchers looked at 633 patients and found that after 48 weeks, 81.3% of those taking both JAKi and 5-ASA achieved remission, compared to 77.0% of those who only received JAKi. The presence of 5-ASA did not significantly change the chances of reaching remission. Who this helps: This information benefits doctors and patients with ulcerative colitis by clarifying treatment options.

Plain English
Researchers studied a type of DNA found outside of chromosomes, called extrachromosomal circular DNA (eccDNA), in patients with inflammatory bowel disease (IBD). They discovered that IBD patients had much higher levels of eccDNA compared to healthy individuals, especially those with active ulcerative colitis, who showed even more significant increases (specific numbers weren’t provided). This finding is important because it could lead to new ways to identify IBD types and monitor disease activity, potentially improving patient care and treatment outcomes. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

Plain English
This study focused on how different scoring systems can predict whether Crohn's disease will return after surgery. Researchers looked at over 170 patients and found that the Rutgeerts score was fairly effective, accurately predicting a clinical recurrence in 83% of cases but was less specific (57%). The study suggests that two newer scoring systems, the POCER index and the UEDA score, may provide better insights into the risk of disease return, particularly for inflammation at the surgical site. Who this helps: This research benefits patients with Crohn's disease by improving the prediction of disease recurrence after surgery, enabling better disease management.

Plain English
This study looked at a specific pathway in the immune system called the IL-33/ST2 axis and its role in helping heal the gut lining in patients with inflammatory bowel disease (IBD), which includes conditions like Ulcerative Colitis and Crohn's disease. Researchers found that targeting this pathway can help improve gut health and support better treatment outcomes, as it is linked to both inflammation and healing. Understanding and modifying this axis could lead to new therapies that are more effective for managing IBD. Who this helps: Patients with inflammatory bowel disease.

Plain English
This research paper looks at how fecal microbiota transplantation (FMT) can be used in mice to study diseases like inflammatory bowel disease (IBD) and short bowel syndrome (SBS). The findings show that FMT can help restore gut health and improve immune function in IBD models, specifically by enhancing beneficial bacteria and restoring gut protection. For SBS, the study highlights challenges in applying FMT due to changes in the intestine but suggests new methods for better results. Who this helps: This helps patients with gastrointestinal diseases and their doctors.

Plain English
This study examined how certain proteins work together in breast cancer cells, specifically in cases where the cancer resists common treatments targeting estrogen receptors. Researchers identified around 104 unique protein structures from 17 different protein groups, finding that changes in these proteins influenced how they interact with treatment pathways. This is important because understanding these protein interactions can lead to the development of more effective therapies for resistant breast cancer. Who this helps: This helps patients with endocrine-resistant breast cancer by guiding treatment development.

Plain English
This study looked at how the size of the bump (called a wheal) from a skin prick test could help predict respiratory allergies like asthma and allergic rhinitis. Researchers found that larger wheal sizes were linked to a higher likelihood of having these allergies, providing a measurable way to assess risk. This matters because it could help doctors diagnose and manage respiratory allergies more effectively based on a simple test. Who this helps: Patients with respiratory allergies and their doctors.

Plain English
This study focused on measuring a property called the electric dipole moment (EDM) of the muon, a subatomic particle. Researchers designed a new way to conduct this measurement using a compact storage device and high-powered magnetic fields, expecting to gather data for 200 days to achieve a certain level of sensitivity in their results. The findings are important because understanding the EDM can reveal new insights into physics, potentially impacting our knowledge of fundamental forces in the universe. Who this helps: This benefits physicists and researchers studying fundamental particles and the forces that govern them.

Plain English
This paper updates the classification of a group of viruses that use RNA to replicate. The International Committee on Taxonomy of Viruses reported adding 270 new species and changing several existing names, which helps clarify how these viruses are related and evolve. This information is important for improving how we identify and manage viral infections, which is vital for public health. Who this helps: This helps public health officials and researchers.

Plain English
This study looked at how a major flood in Thessaly, Greece, in September 2023, affected mosquito populations and the spread of the West Nile virus (WNV). Researchers found that the number of Culex mosquitoes increased significantly in the seven weeks after the flood, but surprisingly, there was no rise in WNV cases among mosquitoes or humans. This is important because it shows that even with ideal conditions for virus spread, other factors can prevent outbreaks, highlighting the need for ongoing monitoring of mosquito populations to effectively manage health risks. Who this helps: Patients and public health officials working to prevent mosquito-borne diseases.

Plain English
This study looked at 14 patients in Italy who experienced a type of severe, persistent seizures known as cryptogenic new-onset refractory status epilepticus (cNORSE) and were treated with a medication called anakinra. The researchers found that patients who started anakinra later tended to spend more time in intensive care, but the treatment did not show any clear long-term benefits for their neurological health. These results highlight the need for further research to better understand effective treatments for this condition. Who this helps: This helps patients suffering from severe epilepsy and their doctors.

Plain English
This study looked at two patients with unexplained neurodevelopmental disorders to better understand the genetic changes causing their conditions. By combining two powerful techniques, whole-genome sequencing and RNA sequencing, researchers identified specific genetic alterations, including disruptions of important genes that are linked to conditions like CHARGE syndrome and Rubinstein-Taybi syndrome. For one patient, this new understanding suggested a potential impact on their health that required further medical evaluation. Who this helps: This benefits patients with undiagnosed neurodevelopmental disorders and their doctors, allowing for more accurate diagnoses and tailored treatment plans.

Plain English
This study looked at how baroreflex sensitivity (BRS)—a measure of how well the body controls blood pressure—might help predict responses to a head-up tilt test in patients who are suspected of having vasovagal syncope (a condition that can cause fainting). Researchers tested 224 patients and found that those with vasovagal syncope had higher BRS levels (7 ms/mmHg) than those without fainting history (4.4 ms/mmHg). Importantly, a BRS value above 6.95 ms/mmHg indicated a positive test result, while a higher value above 8.2 ms/mmHg helped predict instances where the heart would stop during the test. Who this helps: This information benefits patients experiencing unexplained fainting and their doctors in diagnosing and managing their symptoms.

Plain English
This study looked at how knowledge about mushrooms is shared among people in Norway, who are mostly afraid of mushrooms. Researchers set up a series of groups where individuals learned about 24 different mushrooms, including whether they were safe to eat or poisonous. They found that people tended to label mushrooms as poisonous rather than edible, with 90% of participants choosing "poisonous" for the unfamiliar mushrooms. Over time, the details about each mushroom got simplified, mainly focusing on whether they were safe or not, which shows that cultural fears can strongly influence how information about risky plants is passed down. Who this helps: This helps patients and the general public to understand the risks associated with mushroom foraging.

Plain English
This study focused on finding a better way to detect and capture circulating tumor cells (CTCs), which can provide important information about cancer spread. By creating specially designed magnetic platelet decoys, researchers were able to capture these rare cells from blood samples with an effectiveness of at least 58.5%. This is significant because it could improve how cancer is monitored and treated, especially since this method does not depend on specific markers found on the cells, making it more versatile across different cancer types. Who this helps: This benefits cancer patients and doctors by enhancing the ability to track and understand cancer progression.

Plain English
This study examined whether a specific blood test called the Thrombin Generation Assay can predict blood clots in adults newly diagnosed with acute leukemia. Out of 111 patients, only 8 (about 7.2%) experienced thrombotic events during an average follow-up of 8.28 months, but the test results did not reliably indicate who was at risk for these events. This matters because finding better ways to predict complications could improve patient care and outcomes. Who this helps: This helps doctors treating patients with acute leukemia.

Plain English
This study looked at patients undergoing transcatheter aortic valve implantation (TAVI), a procedure that treats severe heart valve narrowing. It found that certain predictors like existing heart conditions and specific anatomy can help determine which patients might need a permanent pacemaker after the procedure; for example, those with a right bundle branch block may be at greater risk. Reducing unnecessary pacemaker installations is important because they can harm long-term health and increase medical costs. Who this helps: This research benefits patients undergoing TAVI, particularly those at risk for heart rhythm complications.

Plain English
This study tracked the changes in the SARS-CoV-2 virus in northern Greece from February 2020 to early 2025 by analyzing 66 samples from hospitalized patients. Researchers identified 34 different virus lineages, with Omicron becoming the dominant strain by May 2022. This information is crucial for public health because it helps monitor how the virus evolves and prepares us for future outbreaks. Who this helps: This benefits public health officials and healthcare providers dealing with COVID-19.

Plain English
This study looked at mosquitoes in Greece to find out if they carried West Nile Virus (WNV) and other related viruses. Researchers tested nearly 46,000 mosquito groups and found WNV in 41 out of 1,316 pools, especially in the Thessaly and Central Macedonia regions during July and September. Knowing where and when these viruses are present helps design better control measures to protect public health. Who this helps: This helps public health officials and local communities in Greece.

Plain English
This study looked at how two medications, Eculizumab and Ravulizumab, affect blood clotting in patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that increases the risk of blood clots. Researchers tested blood samples from nine PNH patients and found that while both medications had similar effects on blood clotting, Ravulizumab led to faster generation of a protein called thrombin, which is involved in clot formation. This matters because it provides insight into the effectiveness of Ravulizumab, which can be given less frequently than Eculizumab, potentially making treatment easier for patients. Who this helps: This study benefits patients with PNH by informing them and their doctors about treatment options.

Plain English
This study looked at Crimean-Congo hemorrhagic fever (CCHF) in Europe, which is caused by a virus spread by ticks. Researchers found over 2,000 reported cases of CCHF in Europe from 1944 to early 2025, mainly concentrated in southern and eastern countries like Bulgaria, Kosovo, and Ukraine. Certain countries were identified as having higher risks for CCHF, which can help public health agencies improve monitoring and responses to keep people safe. Who this helps: This benefits public health officials and communities in at-risk areas.

Plain English
This study focused on how two enzymes, PTEN and PIPP, control a signaling pathway (PI3K/AKT) that drives the growth of breast cancer cells. Researchers found that when both PTEN and PIPP were inactive, breast cancer cells showed significantly increased growth and activity of the AKT signaling pathway, leading to faster cancer progression. Specifically, the loss of both enzymes together was linked to poorer survival in some patients with breast cancer, underscoring the importance of these enzymes in preventing cancer growth. Who this helps: This helps patients with breast cancer and their doctors understand the role of specific enzymes in tumor growth and treatment strategies.

Plain English
In June 2025, two cases of Crimean-Congo haemorrhagic fever were confirmed in Greece, including a death and a healthcare worker who became infected while treating the patient. This was surprising since only one prior case had been reported in the country back in 2008. The situation led to a wide-ranging response to track contacts, improve infection control, and increase awareness and preventive measures, highlighting the importance of monitoring health risks from diseases that neighbors may have. Who this helps: This information is vital for healthcare workers and public health officials to prevent future outbreaks.

Plain English
This study looked at how tick-borne viruses are spread and monitored. Researchers found that these viruses can cause a range of illnesses, from mild symptoms to severe cases that can be deadly. For example, some infections have high fatality rates, highlighting the serious risk they pose to both humans and animals. Who this helps: This helps patients, doctors, and public health officials understand and manage the risks of tick-borne illnesses.

Plain English
This study looked at three inflammatory markers—C-reactive protein, interleukin-6, and fibrinogen—to see if they are just indicators of cardiovascular problems or if they also contribute to those issues. The researchers found that C-reactive protein is linked to worsening atherosclerosis and increased heart attack risk in certain patients; interleukin-6 is associated with higher cholesterol levels and blood vessel issues; and fibrinogen is connected to a higher risk of heart issues in diabetics. Understanding these markers can lead to better treatments and prevention strategies for heart disease. Who this helps: Patients with cardiovascular disease, particularly those with diabetes and those recovering from heart attacks.

Plain English
This study looked at the safety of JAK inhibitors, a type of medication used for treating inflammatory bowel disease (IBD), particularly regarding their potential link to cancer. It found that while there are concerns about cancer risks, these drugs seem to present less risk compared to factors like older age or a history of smoking, which are more significant contributors to cancer development. This information is important because it helps doctors and patients make informed decisions about using JAK inhibitors, knowing the risks involved. Who this helps: Patients with inflammatory bowel disease and their doctors.

Plain English
This research looked at how the bacteria in our gut can affect inflammatory bowel diseases (IBDs) like ulcerative colitis and Crohn's disease. Researchers found that while traditional treatments for IBD are limited, new therapies that change the gut microbiota—like fecal transplants and advanced probiotics—can improve patients' quality of life. This is significant because it opens up new possibilities for treating these chronic conditions. Who this helps: Patients with inflammatory bowel diseases.

Plain English
This study looked at how self-care practices impact resilience in patients with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. It involved 401 patients and found that those who managed their self-care better tended to have higher resilience scores, with an average resilience score of 45. Women reported better resilience and self-care monitoring than men. Improving self-care could lead to better health outcomes for IBD patients. Who this helps: This helps patients with inflammatory bowel disease and their healthcare providers.

Plain English
This research reviewed how gut bacteria affect the treatment of inflammatory bowel disease (IBD). It found that medications can change the types of bacteria in the gut, and these bacteria can also influence how well the drugs work. The study emphasizes the need for a more personalized approach to treating IBD, as individual responses to treatment vary widely. Who this helps: This helps patients with inflammatory bowel disease by improving their treatment outcomes.

Plain English
This study looked at patients with Crohn's disease (CD) to find out what factors might predict the development of short bowel syndrome (SBS), a serious condition where the intestine is too short to absorb enough nutrients. Out of 232 patients, 18 developed SBS, and two key factors were identified: the longer a person has had Crohn's disease, the higher their risk of developing SBS (increase by 8% for every extra year), and having a specific type of gastrointestinal involvement increased the risk significantly (20 times more likely). Understanding these factors is important because it can help doctors monitor patients more closely and potentially prevent the development of SBS. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study focused on creating and testing an Italian version of a questionnaire to measure patient satisfaction with telemedicine for inflammatory bowel disease (IBD). The research involved 180 IBD patients and found that 80% felt telemedicine improved their disease management, while 87% found technology easy to use. This is important because understanding patient satisfaction can help improve telemedicine services and make them a better option for IBD care. Who this helps: Patients with inflammatory bowel disease.

Plain English
This study looked at how inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis are linked to a higher risk of heart and blood vessel problems, especially in younger people and during flare-ups. It found that people with IBD have a consistent but moderate increase in risks for issues like heart attacks and strokes, with the risk getting higher when inflammation is active. The research highlights the importance of managing IBD carefully because effective treatment can lower heart risks. Who this helps: Patients with inflammatory bowel diseases and their healthcare providers.

Plain English
This study examined the effectiveness and safety of the drug filgotinib for treating ulcerative colitis (UC) in patients who had already tried other treatments. Out of 102 patients followed for about six months, 46% achieved clinical remission by the end of the study, and those who started filgotinib first had a higher success rate compared to those on second or third lines of therapy. This research is important as it shows that using filgotinib early in treatment can lead to better outcomes with relatively few adverse effects. Who this helps: This benefits patients with ulcerative colitis, particularly those looking for effective treatment options.

Plain English
This study looked at whether a specific probiotic called Lactobacillus paracasei CNCM I 1572 could help prevent acute diverticulitis (a painful inflammation of the colon) in patients who have mild diverticular disease. Out of 105 participants, only 1 patient taking the probiotic developed acute diverticulitis, compared to 6 patients in the placebo group, showing that the probiotic reduces the risk significantly (p=0.036). This discovery offers a potential new way to prevent complications in patients with diverticular disease. Who this helps: This benefits patients suffering from diverticular disease and their healthcare providers.

Plain English
This study looked at how effective automatic pain assessment systems, powered by artificial intelligence, could be in clinical settings, especially for patients who can't communicate their pain. After surveying 628 healthcare professionals and gathering feedback from 26 pain medicine experts, the researchers found that 96.2% agreed that patients should be informed about how these AI systems work, while 92.3% emphasized the need for proper training and risk management. This matters because these systems could greatly enhance how pain is monitored and managed, especially for individuals who struggle to express their discomfort. Who this helps: This helps patients who cannot communicate their pain effectively, such as those with cognitive impairments or severe disabilities.

Plain English
This study looked at the effectiveness and safety of Upadacitinib (UPA) in treating patients with ulcerative colitis who did not respond to other treatments. Among 202 patients, 45.5% achieved clinical remission at 8 weeks, and by the end of the study, 60.2% were in remission, with 84.6% showing healing in their intestinal lining. The research confirms that UPA is a valuable option for patients with difficult-to-treat ulcerative colitis, with a low rate of serious side effects. Who this helps: Patients with ulcerative colitis who have not had success with other treatments.

Plain English
This research examines how inflammatory bowel disease (IBD) leads to muscle loss, known as sarcopenia. It found that chronic inflammation and changes in gut bacteria and nutrition disrupt muscle health, with specific biological mechanisms identified, such as the activation of certain pathways that promote muscle breakdown. Understanding these processes could lead to better ways to treat or prevent muscle loss in IBD patients, which is crucial since losing muscle can significantly impact their overall health. Who this helps: This helps patients with inflammatory bowel disease.

Plain English
This study looks at a new way of using artificial intelligence called federated learning to improve research on inflammatory bowel diseases while keeping patient data private. Researchers found that federated learning can match or even outperform traditional data handling methods in diagnosing and predicting health outcomes, with performance scores over 0.80 in many cases. This approach is important because it allows different medical institutions to collaborate on creating better predictive models without needing to share sensitive patient information. Who this helps: This helps patients with inflammatory bowel diseases by improving diagnostic tools and treatment predictions.